Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 225

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 225
---
 additional post -closingreview procedures including reviewing historical filings and consulting with subject matter experts related to the accounting for warrant liabilities. APx’s management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation and improvement of it internal control over financial reporting. 94 While APx has processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, APx has expended, and will continue to expend, a substantial amount of effort and resources to improve these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards. The elements of APx’s remediation plan can only be accomplished over time, and APx can offer no assurance that these initiatives will ultimately have the intended effects. In addition, as an emerging growth company, APx currently is not required to comply with Section 404 of the Sarbanes -OxleyAct. As a result, neither APx’s management nor an independent registered public accounting firm has performed an evaluation of APx’s internal control over financial reporting in accordance with the provisions of the Sarbanes -OxleyAct. APx cannot assure you that the measures it has taken to date, and actions it may take in the future, will be sufficient to remediate the control deficiencies that led to these material weaknesses in its internal control over financial reporting or that they will prevent or avoid potential future material weaknesses. Additionally, when evaluating internal controls over financial reporting in the future, APx may identify additional material weaknesses that it may not be able to remediate in advance to the applicable reporting deadlines imposed upon us once it is required to comply with the management assessment reporting requirements of Section 404 of the Sarbanes -OxleyAct. If APx identifies any additional material weaknesses in its internal control over financial reporting or it is unable to remediate the material weakness described above or comply with the requirements of Section 404 of the Sarbanes -OxleyAct in a timely manner or its independent registered public accounting firm is unable to express an unqualified opinion as to the effectiveness of its internal control over financial reporting once it are no longer an emerging growth company, or APx is unable to conclude in its quarterly and annual reports that its disclosure controls and procedures are effective, investors may lose confidence in the accuracy and completeness of its financial reports and the market price of APx’s ordinary shares could be negatively affected, and it could become subject to investigations by the stock exchange on which its